BM-09 USE OF NEUROENDOSCOPY TO SAFELY DELIVER INTRATHECAL CHEMOTHERAPY AT THE TIME OF OMMAYA RESERVOIR PLACEMENT

Por Chu, Ray, Rudnick, Jeremy, Natale, Ronald
Publicado em 2014

Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

Por Pike, Crystal T., Birnbaum, Howard G., Muehlenbein, Catherine E., Pohl, Gerhardt M., Natale, Ronald B.
Publicado em 2012

Pharmacokinetic study of aldoxorubicin in patients with solid tumors

Por Mita, Monica M., Natale, Ronald B., Wolin, Edward M., Laabs, Brenda, Dinh, Hillary, Wieland, Scott, Levitt, Daniel J., Mita, Alain C.
Publicado no Invest New Drugs (2014)

Common arm comparative outcomes analysis of phase III trials of cisplatin + irinotecan vs. cisplatin + etoposide in extensive stage small cell lung cancer: Final patient-level resu...

Por Lara, Primo N., Chansky, Kari, Shibata, Taro, Fukuda, Haruhiko, Tamura, Tomohide, Crowley, John, Redman, Mary W., Natale, Ronald, Saijo, Nagahiro, Gandara, David R
Publicado em 2010

Epithelial membrane protein-1 is a biomarker of gefitinib resistance

Por Jain, Anjali, Tindell, Charles A., Laux, Isett, Hunter, Jacob B., Curran, John, Galkin, Anna, Afar, Daniel E., Aronson, Nina, Shak, Steven, Natale, Ronald B., Agus, David B.
Publicado em 2005

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant chemotherapy

Por Sonpavde, Guru, Goldman, Bryan H., Speights, V.O., Lerner, Seth P., Wood, David P., Vogelzang, Nicholas J., Trump, Donald L., Natale, Ronald B., Grossman, H. Barton, Crawford, E. David
Publicado em 2009

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Por Lara, Primo N., Natale, Ronald, Crowley, John, Lenz, Heinz Josef, Redman, Mary W., Carleton, Jane E., Jett, James, Langer, Corey J., Kuebler, J. Philip, Dakhil, Shaker R., Chansky, Kari, Gandara, David R.
Publicado em 2009

Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients...

Por Natale, Ronald, Blackhall, Fiona, Kowalski, Dariusz, Ramlau, Rodryg, Bepler, Gerold, Grossi, Francesco, Lerchenmüller, Christian, Pinder-Schenck, Mary, Mezger, Jörg, Danson, Sarah, Gadgeel, Shirish M., Summers, Yvonne, Callies, Sophie, André, Valérie, Das, Mayukh, Lahn, Michael, Talbot, Denis
Publicado no J Thorac Oncol (2014)

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Por Sequist, Lecia V., Gettinger, Scott, Senzer, Neil N., Martins, Renato G., Jänne, Pasi A., Lilenbaum, Rogerio, Gray, Jhanelle E., Iafrate, A. John, Katayama, Ryohei, Hafeez, Nafeeza, Sweeney, Jennifer, Walker, John R., Fritz, Christian, Ross, Robert W., Grayzel, David, Engelman, Jeffrey A., Borger, Darrell R., Paez, Guillermo, Natale, Ronald
Publicado no J Clin Oncol (2010)